COVID-19 ARDS n = 24 | Influenza ARDS n = 18 | Bacterial CAP ARDS n = 11 | p-value | |
---|---|---|---|---|
Age (years) | 57.5 [50.75;67] | 58 [51.75;72.75] | 66 [57;71.5] | 0.38 |
Male sex | 17/24 (71%) | 10/18 (56%) | 8/11 (73%) | 0.56 |
Chronic pulmonary disease | 3/24 (12%) | 9/18 (50%) | 6/11 (55%) | < 0.01 |
COPD | 3/24 (12%) | 5/18 (28%) | 4/11 (36%) | 0.2 |
Asthma | 0/24 (0%) | 4/18 (22%) | 1/11 (9.1%) | 0.03 |
Current smoking | 4/24 (17%) | 4/18 (22%) | 3/11 (27%) | 0.75 |
Chronic kidney disease | 0/16 (0%) | 1/18 (5.6%) | 0/11 (0%) | 1 |
Obesity | 5/23 (22%) | 5/18 (28%) | 1/11 (9.1) | 1 |
Diabetes mellitus | 4/23 (17%) | 3/18 (17%) | 1/11 (9.1%) | 1 |
Heart coronary disease | 6/24 (25%) | 4/18 (22%) | 6/11 (55%) | 0.18 |
High blood pressure | 7/16 (44%) | 6/18 (33%) | 4/11 (36%) | 0.92 |
Immunodepression | 4/24 (17%) | 0/18 (0%) | 2/11 (18%) | 0.11 |
Long-term systemic corticosteroids | 1/24 (4.2%) | 1/18 (5.6%) | 0/11 (0%) | 1 |
Antibiotics before admission | 5/16 (31%) | 3/10 (30%) | 1/10 (10%) | 0.5 |
Antifungals before admission | 0/16 (0%) | 0/10 (0%) | 0/10 (0%) | 1 |
PPI | 2/24 (8.3%) | 0/10 (0%) | 1/11 (9.1%) | 1 |
Metformin | 1/23 (4.3%) | 1/17 (5.9%) | 1/11 (9.1%) | 1 |
SAPS 2 | 47.5 [35.5;56.75] | 45 [31.25;57.5] | 68.5 [53.5;86] | 0.08 |
Heart rate (/min) | 91 [80;108] | 98.5 [73;110.75] | 90 [80;116] | 0.85 |
Respiratory rate (/min) | 26 [25.25;29.75] | 25.5 [22.25;28] | 32.5 [24.75;40] | 0.22 |
Mean blood pressure (mmHg) | 85 [78;97] | 86.5 [78.5;101] | 84 [78.75;93.25] | 0.92 |
PaO2/FiO2 | 140 [132;204] | 150 [121.7;206.2] | 120 [91;144.5] | 0.19 |
Neutrophils count (/mm3) | 8340 [5227;11160] | 4980 [3412;7750] | 7460 [2465;10935] | 0.07 |
Lymphocytes count (/mm3) | 660 [540;862.5] | 750 [402.5;1142.5] | 340 [225;1070] | 0.6 |
Fibrinogen (g/L) | 9.6 [8.55;9.9] | 6.5 [6.125;8.25] | 7.7 [5.2;9.6] | 0.06 |
CRP (mg/L) | 189 [116;286] | 47 [41;1,006] | 159 [101;214] | 0.15 |
Septic shock | 11/24 (46%) | 3/18 (17%) | 7/11 (64%) | 0.026 |
Acute kidney injury | 6/16 (38%) | 5/18 (28%) | 6/11 (55%) | 0.37 |
Day 28 survival | 19/24 (79%) | 15/18 (83%) | 7/11 (64%) | 0.48 |